EDAP TMS gains CE mark for device to treat prostate cancer

06/20/2013 | MedGadget.com

EDAP TMS has earned the CE mark in Europe for its Focal•One robotic High-Intensity Focused Ultrasound device, which is used to treat prostate cancer patients in a noninvasive manner. The device combines MRI with real-time ultrasound imaging to target tumors better during therapy, among other features.

View Full Article in:

MedGadget.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY